Demonstrates NIR-II imaging efficacy for inflammatory bowel disease, highlighting innovative biomedicine applications.
topology and shows a maximum emission peak at 1052 nm. The HIAM-4030-based nanocomposite exhibits targeted delivery, anti-inflammatory efficacy, and real-time, noninvasive visualization of inflammatory bowel disease via NIR-II fluorescence imaging. This work sheds light on the rational design and construction of luminescent metal-organic frameworks with NIR-II emission behaviors for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: